Lynn K Martin, MD | |
2550 Waukegan Rd, Suite 100, Glenview, IL 60025-1777 | |
(847) 729-2541 | |
(847) 729-2546 |
Full Name | Lynn K Martin |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Location | 2550 Waukegan Rd, Glenview, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003975558 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | (Illinois) | Primary |
Entity Name | Northshore University Healthsystem Faculty Practice Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
Senior citizens who hit the so-called doughnut hole in Medicare's drug benefit will begin getting $250 rebate checks in two weeks, the Obama administration announced Thursday — providing one of the first tangible benefits of the recently enacted healthcare law. The rebates, designed in part to bolster support for the controversial law, are the first steps in a decade-long phase-out of the unpopular gap in Medicare Part D drug coverage.
Antibiotics are more efficient when they can act on their target directly at the site of infestation, without dilution.
In a recent paper published in the Journal of Biological Chemistry Yuna Ayala, Ph.D., assistant professor of biochemistry and molecular biology at Saint Louis University, and her research team made advances in understanding how a protein causes damaging plaques to build up in neurodegenerative illnesses like amyotrophic lateral sclerosis (ALS) and a form of dementia called frontotemporal lobar degeneration.
To better predict, study and diagnose small vessel disease in the brain and its role in vascular contributions to cognitive impairment and dementia (VCID), Boston University School of Medicine has been selected to participate in MarkVCID, a consortium designed to accelerate the development of new and existing biomarkers for small vessel VCID.
Keryx Biopharmaceuticals, Inc., announced today that its Japanese partner, Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd., has announced positive top-line results from a Phase 3 study of ferric citrate in Japan for the treatment of hyperphosphatemia in end-stage renal disease patients on hemodialysis.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Lynn K Martin, MD 2650 Ridge Ave, Evanston Hospital, Evanston, IL 60201-1718 Ph: (847) 570-1206 | Lynn K Martin, MD 2550 Waukegan Rd, Suite 100, Glenview, IL 60025-1777 Ph: (847) 729-2541 |
News Archive
Senior citizens who hit the so-called doughnut hole in Medicare's drug benefit will begin getting $250 rebate checks in two weeks, the Obama administration announced Thursday — providing one of the first tangible benefits of the recently enacted healthcare law. The rebates, designed in part to bolster support for the controversial law, are the first steps in a decade-long phase-out of the unpopular gap in Medicare Part D drug coverage.
Antibiotics are more efficient when they can act on their target directly at the site of infestation, without dilution.
In a recent paper published in the Journal of Biological Chemistry Yuna Ayala, Ph.D., assistant professor of biochemistry and molecular biology at Saint Louis University, and her research team made advances in understanding how a protein causes damaging plaques to build up in neurodegenerative illnesses like amyotrophic lateral sclerosis (ALS) and a form of dementia called frontotemporal lobar degeneration.
To better predict, study and diagnose small vessel disease in the brain and its role in vascular contributions to cognitive impairment and dementia (VCID), Boston University School of Medicine has been selected to participate in MarkVCID, a consortium designed to accelerate the development of new and existing biomarkers for small vessel VCID.
Keryx Biopharmaceuticals, Inc., announced today that its Japanese partner, Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd., has announced positive top-line results from a Phase 3 study of ferric citrate in Japan for the treatment of hyperphosphatemia in end-stage renal disease patients on hemodialysis.
› Verified 2 days ago
Karen Chiu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Pfingsten Rd Ste 3001a, Glenview, IL 60026 Phone: 847-657-5840 Fax: 847-657-5732 | |
Dr. Jamee Castillo Tantoco, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2050 Pfingsten Rd Ste 320, Glenview, IL 60026 Phone: 847-998-4170 Fax: 847-998-4165 | |
Dr. Gregory Aaron Wallman, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2501 Compass Rd, Suite 100, Glenview, IL 60026 Phone: 847-901-5200 Fax: 847-904-4907 | |
Rebecca Wanting Tsang, M.D., M.P.H. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2150 Pfingsten Rd Ste 3000, Glenview, IL 60026 Phone: 847-657-1900 | |
Dr. Monica S. Borkar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Pfingsten Rd, Suite B230, Glenview, IL 60026 Phone: 847-657-1900 Fax: 847-657-1961 | |
Joel R. Green, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Pfingsten Rd Ste 3001a, Glenview, IL 60026 Phone: 847-657-5840 Fax: 847-657-5835 |